You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Lung Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 2 | Results 1 - 10 of 11

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

Cancer - Lung

D'Amour Center for Cancer Care, 3350 Main Street, Springfield, MA 01199

Recruiting

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Cancer, Cancer - Lung

D'Amour Center for Cancer Care, 3350 Main Street, Springfield, MA 01199

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Molecular Analysis for Therapy Choice (MATCH)

Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)

Cancer, Cancer - Lung

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (DART)

Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA   

Recruiting
Page 1 of 2 | Results 1 - 10 of 11